Indian Army Drug Tender Procurement 2026 – Chemotherapy & Onco Drugs Supply into Military Health, EMD ₹30000
Bid Publish Date
24-Oct-2026, 11:54 am
Bid End Date
03-Nov-2026, 12:00 pm
EMD
₹30,000
Location
Progress
Tender Overview
The Indian Army (Department Of Military Affairs) seeks supply of multiple chemotherapy and oncology injections and related medicines, encompassing 15 items across various dosages and formulations. The estimated value is not disclosed, but the tender carries an EMD of ₹30,000. The procurement location is not specified, and the start/end dates are absent. A key commercial feature is the Purchaser’s option to adjust order quantities by up to 25% during contract execution, with corresponding delivery-time adjustments. This framework demands robust regulatory compliance and reliable cold-chain distribution for injectable products.
Technical Specifications & Requirements
- No explicit product specs are listed in the BOQ; however, the catalog includes: NAB Paclitaxel injections (30 mg, 100 mg, 300 mg), Gemcitabine variants (1000 mg, 1400 mg, 200 mg, 600? mg), Ep irubicin variants (20, 50, 100 mg), Ruxolitinib 5 mg tab, Filgrastim 300 mcg, and Leuprolide Depot 3.75 mg. The buyer’s ATC document is referenced but not visible here. The clause implies conformity to pharmaceutical procurement norms and cold-chain handling.
- Important elements to verify include packaging, shelf-life, cold chain suitability, storage conditions, and batch traceability. The absence of explicit IS/ISO standards suggests bidders must rely on standard pharmaceutical GMP compliance and OEM authorizations.
- Delivery and extension rules are governed by the option clause, with delivery-time calculations linked to original quantities and periods. Bidders should prepare for potential quantity fluctuations up to 25%, with timely performance under extended timelines.
Terms, Conditions & Eligibility
- EMD: ₹30,000; specify payment method as per tender terms.
- Quantity: up to 25% increase/decrease at contract award and during execution.
- Delivery: periods extendable via option clause; minimum extension logic applies.
- Documents: GST, PAN, experience certificates, financials, EMD proof, OEM authorizations, and technical bids.
- Terms emphasize compliance with ATC once viewed; bidders should review the uploaded ATC document before submission.
Key Specifications
-
15 total items with injectable oncology and supporting drugs
-
EMD amount: ₹30,000
-
Quantity flexibility up to 25% during contract
-
No explicit standard numbers specified in the tender excerpt
-
ATC document referenced but not attached
Terms & Conditions
-
EMD of ₹30,000 required to participate
-
Adjustment of order quantity up to 25% during contract
-
Delivery period extension rules based on option clause
Important Clauses
Payment Terms
EMD amount ₹30,000; payment terms to be as per ATC and supplier invoicing
Delivery Schedule
Delivery periods extendable via option clause; extended time proportional to quantity change
Penalties/Liquidated Damages
Not explicitly stated in the excerpt; bidders should refer to ATC document for LD terms
Bidder Eligibility
-
Experience in supplying pharmaceutical injectables to government bodies
-
GST registered with valid certifications
-
OEM authorization for listed drug categories and dosages
Tender Data
Bid Details
Quantity
214
Category
Tremelimumab 300 mg Inj
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
Yes
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Tremelimumab 300 mg Inj , Carboplatin 150 mg Inj , Bortezumab 2 mg Inj , Gemcitabine 1400 mg Inj , Gemcitabine 200 mg Inj , Gemcitabine 1000 mg Inj , Filgratim Pfs 300 mcg Inj , NAB Paclitaxel 100 mg Inj , NAB Paclitaxel 30 mg Inj , NAB Paclitaxel 300 mg Inj , Leuprolide Depot 3.75 mg Inj , Epirubicin 100 mg Inj , Epirubicin 50 mg Inj , Epirubicin 20 mg Inj , Ruxolitinib 5 mg Tab
Advisory Bank
State Bank of India
ePBG Percentage
3%
ePBG Duration (Months)
24
Delivery Details
Max Delivery Days
20
Delivery Locations
1
Delivery Cities
Aurangabad
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Aurangabad | Aurangabad | - | - | 1 | 20 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-10034007.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
15 Items Sign in to view GEM price trends Sign in for GEM prices
Tremelimumab 300 mg Inj
Tremelimumab 300 mg Inj
Carboplatin 150 mg Inj
Carboplatin 150 mg Inj
Bortezumab 2 mg Inj
Bortezumab 2 mg Inj
Gemcitabine 1400 mg Inj
Gemcitabine 1400 mg Inj
Gemcitabine 200 mg Inj
Gemcitabine 200 mg Inj
Gemcitabine 1000 mg Inj
Gemcitabine 1000 mg Inj
Filgratim Pfs 300 mcg Inj
Filgratim Pfs 300 mcg Inj
NAB Paclitaxel 100 mg Inj
NAB Paclitaxel 100 mg Inj
NAB Paclitaxel 30 mg Inj
NAB Paclitaxel 30 mg Inj
NAB Paclitaxel 300 mg Inj
NAB Paclitaxel 300 mg Inj
Leuprolide Depot 3.75 mg Inj
Leuprolide Depot 3.75 mg Inj
Epirubicin 100 mg Inj
Epirubicin 100 mg Inj
Epirubicin 50 mg Inj
Epirubicin 50 mg Inj
Epirubicin 20 mg Inj
Epirubicin 20 mg Inj
Ruxolitinib 5 mg Tab
Ruxolitinib 5 mg Tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Tremelimumab 300 mg Inj | Tremelimumab 300 mg Inj | 1 | vial | po3gem | 20 | |
| 2 | Carboplatin 150 mg Inj | Carboplatin 150 mg Inj | 12 | vial | po3gem | 20 | |
| 3 | Bortezumab 2 mg Inj | Bortezumab 2 mg Inj | 4 | vial | po3gem | 20 | |
| 4 | Gemcitabine 1400 mg Inj | Gemcitabine 1400 mg Inj | 7 | vial | po3gem | 20 | |
| 5 | Gemcitabine 200 mg Inj | Gemcitabine 200 mg Inj | 7 | vial | po3gem | 20 | |
| 6 | Gemcitabine 1000 mg Inj | Gemcitabine 1000 mg Inj | 7 | vial | po3gem | 20 | |
| 7 | Filgratim Pfs 300 mcg Inj | Filgratim Pfs 300 mcg Inj | 8 | pfs | po3gem | 20 | |
| 8 | NAB Paclitaxel 100 mg Inj | NAB Paclitaxel 100 mg Inj | 10 | vial | po3gem | 20 | |
| 9 | NAB Paclitaxel 30 mg Inj | NAB Paclitaxel 30 mg Inj | 10 | vial | po3gem | 20 | |
| 10 | NAB Paclitaxel 300 mg Inj | NAB Paclitaxel 300 mg Inj | 10 | vial | po3gem | 20 | |
| 11 | Leuprolide Depot 3.75 mg Inj | Leuprolide Depot 3.75 mg Inj | 3 | vial | po3gem | 20 | |
| 12 | Epirubicin 100 mg Inj | Epirubicin 100 mg Inj | 5 | vial | po3gem | 20 | |
| 13 | Epirubicin 50 mg Inj | Epirubicin 50 mg Inj | 5 | vial | po3gem | 20 | |
| 14 | Epirubicin 20 mg Inj | Epirubicin 20 mg Inj | 5 | vial | po3gem | 20 | |
| 15 | Ruxolitinib 5 mg Tab | Ruxolitinib 5 mg Tab | 120 | nos | po3gem | 20 |
Categories
1
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates of similar pharmaceutical supply
Financial statements (last 2-3 years)
EMD/Security deposit receipt
Technical bid and compliance certificates
OEM authorizations or authorized distributor certificates
Any regulatory approvals specific to pharmaceutical injections
Frequently Asked Questions
Key insights about MAHARASHTRA tender market
How to bid for Indian Army chemotherapy drug tender 2026?
Bidders must submit GST, PAN, experience certificates, financial statements, and EMD ₹30,000 along with technical bid. OEM authorizations and ATC-compliant documentation are required. Ensure items meet pharmaceutical regulatory standards and cold chain capabilities; review the uploaded ATC for specific conditions and delivery timelines.
What documents are required for Indian Army medical supply bid 2026?
Required documents include GST certificate, PAN, two to three years of financials, experience certificates for similar government procurement, EMD receipt of ₹30,000, technical bid with compliance statements, OEM authorization, and regulatory approvals for injectable drugs. Ensure documents are current and properly notarized where applicable.
What are the delivery and quantity adjustment rules in this tender?
Contract allows up to 25% quantity adjustment during placement and currency. Delivery periods extend proportionally with the increased quantity; minimum extension is 30 days if original period is shorter. Submit a flexible delivery plan aligned with the option clause and target timelines.
Which items are included in the 15 item pharmaceutical list?
The list includes NAB Paclitaxel injections (30 mg, 100 mg, 300 mg), Gemcitabine variants (1000 mg, 1400 mg, 200 mg), Epirubicin variants (20, 50, 100 mg), Filgrastim 300 mcg, Leuprolide Depot 3.75 mg, Ruxolitinib 5 mg, among others. Exact item names appear in the BOQ; verify against the ATC document.
What is the EMD amount for this pharma tender in India?
The EMD amount is ₹30,000. Ensure payment is completed and receipt is submitted with the bid. Refer to ATC for any additional payment milestones or adjustments linked to quantity changes.
What are the essential eligibility criteria for this Indian Army bid?
Eligible bidders must have pharmaceutical supply experience to government bodies, valid GST and PAN, financial stability evidenced by statements, and OEM authorizations for listed anti-cancer drugs. Compliance with ATC terms and demonstrated cold-chain logistics capability are required.